Congruence Therapeutics Appoints Frank Taffy as Chief Business Officer
-Mr. Taffy joins from Schrödinger, bringing a wealth of relevant expertise to Congruence- MONTREAL, April 23, 2024 /PRNewswire/ -- Congruence Therapeutics, a leading computationally-driven biotechnology company developing a pipeline of novel …